Qilian International Holding - QLI Quarterly Revenue Growth

Official company branding of qlsyy.net (QLI)

Amid strict government regulation and the competition for public procurement, Qilian International relies on its licorice product production volumes and portfolio diversification. This quarterly revenue chart on GURU.Markets shows that the current parameter is -46.70. This trend reflects the impact of China's environmental oversight on capacity expansion within a closed B2B raw materials ecosystem.

QLI (Qilian International Holding Group Limited) Quarterly Revenue Growth history from 07/04/2022 to 08/17/2024

Analytical breakdowns for Qilian International Holding (QLI)

- current quotes and average value forecast:
- cash balance and cash flow data:
Fundamental company analysis:QLI - Qilian International Holding
Flagship merchandise of qlsyy.net

Comparative asset analysis requires an assessment of capital inflow rates, where this indicator measures the percentage deviation of current revenue from previous quarter figures to identify operational resilience. For Qilian International (QLI), which specializes in high-purity licorice extracts, the relative quarterly revenue change confirms the demand for organic raw materials among industrial partners, reflecting the brand's actual market value.

Direct competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Sales Growth Theravance Biopharma, Inc. (TBPH)|Quarterly Sales Growth AQST (Aquestive Pharma)|SCPH - Quarterly Revenue Growth Rate|Quarterly Revenue Growth TECX (Tectonic Therapeutic, Inc.)|TNXP - Quarterly Sales Growth|China SXT Pharmaceuticals, Inc. - Quarterly Revenue Growth|EPRX - Quarterly Revenue Growth|BHST: Quarterly Revenue Growth|Quarterly Revenue Growth Rate eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Quarterly Revenue Growth|Sales Growth QoQ ENTX (Entera Bio)|Revenue Growth QoQ MindWalk (HYFT)|Quarterly Revenue Growth ABVC BioPharma, Inc. (ABVC)|Revenue Growth QoQ Cumberland Corp CPIX|QNTM - Quarterly Sales Growth|FGEN - Revenue Growth QoQ|TELO - Quarterly Revenue Growth|Rani Therapeutics Inc (RANI) - Revenue Growth QoQ|Sales Growth QoQ SNYR|Revenue Growth QoQ Rallybio Corp|Revenue Growth QoQ LEXX|Quarterly Revenue Growth PULM|PTHL: Revenue Dynamics QoQ|Quarterly Revenue Growth APM (Aptorum Group Ltd)|LYRA - Quarterly Sales Growth|Impact BioMedical Inc - Quarterly Revenue Growth|Revenue Dynamics QoQ TNFA|YCBD (cbdmd.com) - Quarterly Sales Growth|painreform.com - Quarterly Revenue Increase|Quarterly Sales Growth CYTO|Revenue Growth QoQ LIPO|Revenue Growth QoQ optinose.com (OPTN)|PIRS (Pieris Pharma) - Quarterly Revenue Increase|Revenue Growth QoQ Procaps Group S.A. PROC|Quarterly Sales Growth Rate petrospharma.com (PTPI)|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)